查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1997182

人工智慧手术机器人市场：按组件、机器人系统类型、自主等级、应用和最终用户划分－2026-2032年全球市场预测

AI-based Surgical Robots Market by Component, Robotic System Type, Level of Autonomy, Application Areas, End-User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，人工智慧手术机器人市场价值将达到 67.5 亿美元，到 2026 年将成长至 70.9 亿美元，到 2032 年将达到 103.4 亿美元，复合年增长率为 6.27%。

主要市场统计数据
基准年 2025 67.5亿美元
预计年份：2026年 70.9亿美元
预测年份 2032 103.4亿美元
复合年增长率 (%) 6.27%

本文简要概述了人工智慧驱动的手术机器人如何透过整合临床精准性、数据生态系统和创新采购模式来重新定义外科手术服务的提供方式。

人工智慧（AI）驱动的手术机器人的出现，将机械精度与演算法决策支援相结合，拓展了临床应用的可能性，并重塑了手术的规划、引导和执行方式。这些技术正将外科手术实践从单纯的手工操作转变为一个整合的数位生态系统，在这个系统中，成像、感测和数据分析相互融合，从而提高术中精度和术后效果。医院、专科诊所和门诊手术中心的相关人员正在评估实施这些技术所带来的各种权衡，包括临床效益、工作流程整合、人员培训和实施复杂性。

自主性、人工智慧成像、身临其境型模拟和不断发展的法规等方面的进步如何结合起来，将手术机器人转变为可互通的临床平台。

手术机器人领域正经历着一场变革性的转型，这主要得益于机器学习、感测器小型化和人机介面设计的进步。这些因素的结合正在提升系统的自主性和临床效用。如今，术中决策支援系统利用多模态成像和长期结果资料训练的模型，从而能够提供情境化的指导，而不仅仅是简单地复製操作。这项进展正在加速从以工具为中心的自动化向以平台为中心的生态系统转变，后者整合了软体、硬体和服务。

2025 年美国关税措施将如何影响外科机器人产业的供应链重组、零件采购转变和韧性策略？

美国将于2025年实施的关税将对用于手术机器人平台的高精度零件和子系统组件的全球供应链造成巨大压力。依赖跨境采购控制电子设备、成像模组和专用致动器的製造商正面临采购成本上升和前置作业时间波动加剧的困境，迫使他们进行策略调整，转向供应商多元化和近岸外包。这些调整通常需要对零件供应商进行重新认证并更新监管申请，这需要额外的时间和合规投入。

详细的细分洞察揭示了组件架构、自主层级、系统类型、临床应用和最终用户需求如何塑造策略和差异化。

对市场区隔的深入理解揭示了影响产品开发和市场进入策略的独特技术和商业性趋势。在考虑组件时，控制系统、成像系统、机械臂、感测器和致动器等硬体类别构成了平台性能的基础，而安装、培训、维护和支援等服务则决定了生命週期成本和临床运作。此外，由人工智慧和机器学习演算法、用于手术模拟的扩增实境(AR) 和虚拟实境 (VR) 技术以及资料分析和决策支援系统组成的软体层，正日益成为提供临床价值和持续收入的差异化因素。在评估机器人系统类型时，可以明显看出以下差异：以演算法决策为优先的人工智慧驱动的自主机器人系统；依赖固定电源、资料链路并整合到现有手术室的有线机器人系统；以及为便携性和受限环境提供新型部署模式的无线机器人系统。

美洲、欧洲、中东和非洲以及亚太地区的区域临床重点、监管环境和製造生态系统如何决定战略市场方法。

区域趋势潜移默化地影响着产品优先顺序、监管互动和商业化策略。在美洲，医疗保健系统强调大规模网路采购、与电子健康记录的整合以及以结果为导向的采购，而创新丛集促进医疗设备製造商和手术中心之间的紧密合作，从而推动器械设计改进和真实世界数据（REW）的生成。这种环境有利于快速试点部署，但同时也需要强有力的安全性和有效性证据，以确保在不同类型的医院中广泛应用。

竞争动态的形成，源自于成熟企业进入软体生态系统、Start-Ups创新自主技术，以及推动整合临床解决方案和差异化的伙伴关係。

手术机器人领域的竞争格局呈现出两极化的特点：一方面是成熟的医疗设备製造商正将业务拓展至软体主导服务领域；另一方面是敏捷的Start-Ups公司，它们专注于自主性、特定应用或新型人机互动介面。大型成熟企业凭藉丰富的部署经验、稳固的医院合作关係以及支援部署的临床试验网络，保持领先优势。然而，新兴企业正迅速迎头赶上，它们利用机器学习、模组化硬体设计以及云端原生软体的突破性进展，这些软体可以在部署后进行迭代更新，从而提升效能并增加功能。

市场领导可采取的策略重点是平衡模组化设计、监管合规规划、培训生态系统、软体货币化和供应链弹性。

产业领导者应优先采取一系列策略行动，以管理风险并在快速发展的生态系统中创造临床价值。首先，投资于模组化产品架构，将专有子系统与通用组件分离，以减轻关税相关成本波动的影响，并实现分阶段升级，而无需更换整个平台。这种设计方法支援区域製造柔软性，并缩短国际客户的服务回应时间。其次，将监管合规性和真实世界证据 (REW) 规划整合到产品开发生命週期中，以简化核准流程，并建立保险公司和医疗保健系统部署所需的可靠结果报告。儘早与监管机构和保险公司合作将减少上市后摩擦，并改善报销谈判。

采用稳健的混合调查方法，结合专家访谈、第二手资料整合、基准测试和情境分析，以检验策略见解和趋势。

这些研究成果的研究途径结合了对一手定性资料的结构化审查和透过二手资讯进行的严格检验，以确保分析的完整性。一手研究包括对外科医生、采购负责人和医疗设备工程师的深度访谈，以获取关于临床效用、推广障碍和采购考量的第一手观点。除了这些访谈之外，还咨询了监管和卫生经济学专家，以明确营运环境中的合规性和报销影响。

这是一份全面的指南，旨在透过实际应用、培训和强大的商业化，将机器人和人工智慧创新转化为可重复的临床价值。

先进机器人技术、人工智慧和身临其境型模拟的融合正开启外科医学的新篇章，其特点是精准度和可重复性显着提升，并有望扩大高品质治疗的覆盖范围。相关人员必须应对日益复杂的临床证据要求、监管预期和经济压力之间的相互作用，同时抓住软体主导的差异化和服务导向型商业模式所带来的机会。成功的关键在于使产品设计与临床医生的工作流程相契合，展现可衡量的临床和营运效益，并建立稳健的供应和支援体系。

目录

第一章：序言

第二章：调查方法

  • 调查设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查的前提
  • 研究限制

第三章执行摘要

  • 首席主管观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会映射
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章：人工智慧手术机器人市场：按组件划分

  • 硬体
    • 控制系统
    • 影像系统
    • 机械臂
    • 感测器和致动器
  • 服务
    • 安装和培训
    • 维护和支援
  • 软体
    • 人工智慧和机器学习演算法
    • 扩增实境（AR）和虚拟实境（VR）在外科手术模拟中的应用
    • 数据分析与决策支援系统

第九章：按机器人系统类型分類的人工智慧手术机器人市场

  • 人工智慧驱动的自主机器人系统
  • 有线机器人系统
  • 无线机器人系统

第十章：以自主程度分類的人工智慧手术机器人市场

  • 全自动手术机器人
  • 半自动自主手术机器人
  • 受监督的人工智慧辅助机器人

第十一章：按应用分類的人工智慧手术机器人市场

  • 心胸外科
  • 一般外科
  • 妇科手术
  • 神经外科
  • 整形外科
  • 泌尿系统手术

第十二章：人工智慧手术机器人市场：按最终用户划分

  • 门诊手术中心
  • 医院
  • 专科诊所

第十三章：人工智慧手术机器人市场：按地区划分

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十四章：人工智慧手术机器人市场：依组别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十五章：人工智慧手术机器人市场：按国家划分

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

第十六章：美国人工智慧手术机器人市场

第十七章：中国人工智慧手术机器人市场

第十八章 竞争格局

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Accuray Incorporated
  • Activ Surgical, Inc.
  • Asensus Surgical US, Inc.
  • CMR Surgical Limited
  • Globus Medical, Inc.
  • Intuitive Surgical, Inc.
  • Johnson & Johnson Services, Inc.
  • KUKA AG
  • Medtronic PLC
  • Monteris Medical Corporation
  • Moon Surgical
  • Neocis, Inc.
  • Noah Medical Corporation
  • Olympus Corporation
  • Robocath SAS
  • Shimadzu Corporation
  • Siemens AG
  • Smith & Nephew PLC
  • Stereotaxis, Inc.
  • Stryker Corporation
  • Synaptive Medical Inc.
  • THINK Surgical, Inc.
  • Titan Medical Inc.
  • Virtual Incision Corporation
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-035590447F03

The AI-based Surgical Robots Market was valued at USD 6.75 billion in 2025 and is projected to grow to USD 7.09 billion in 2026, with a CAGR of 6.27%, reaching USD 10.34 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.75 billion
Estimated Year [2026] USD 7.09 billion
Forecast Year [2032] USD 10.34 billion
CAGR (%) 6.27%

A succinct framing of how AI-driven surgical robotics are converging clinical precision, data ecosystems, and novel procurement models to redefine surgical care delivery

The emergence of artificial intelligence-driven surgical robots is reshaping how surgery is planned, guided, and executed, combining mechanical precision with algorithmic decision support to expand clinical possibilities. These technologies are shifting surgical practice from manual dexterity alone to an integrated digital ecosystem where imaging, sensing, and data analytics converge to improve intraoperative accuracy and postoperative outcomes. Stakeholders across hospitals, specialty clinics, and ambulatory surgical centers are evaluating adoption trade-offs that include clinical benefit, workflow integration, staff training, and procurement complexity.

Clinical teams are increasingly exposed to systems that augment surgeon capabilities through enhanced visualization, tremor filtration, and predictive assistance. As a result, adoption considerations extend beyond device performance to encompass software lifecycle management, cybersecurity posture, and interoperability with electronic health records and imaging archives. Simultaneously, vendors are adapting business models to deliver subscription-based software updates, training-as-a-service, and outcome-linked maintenance, which require new procurement constructs and contracting frameworks.

This introduction positions the technology as a multifaceted value proposition that intersects clinical efficacy, operational efficiency, and long-term digital strategy. It sets the stage for a deeper exploration of how technological maturation, regulatory pathways, and economic pressures are catalyzing the next wave of surgical innovation across care environments.

How advances in autonomy, AI-enhanced imaging, immersive simulation, and regulatory evolution are collectively transforming surgical robotics into interoperable clinical platforms

The landscape for surgical robotics is undergoing transformative shifts driven by advances in machine learning, sensor miniaturization, and human-machine interface design that collectively elevate system autonomy and clinical utility. Intraoperative decision support now benefits from models trained on multimodal imaging and longitudinal outcomes, enabling tools that provide context-aware guidance rather than simple motion replication. This progression fosters a move from tool-centric automation to platform-centric ecosystems that integrate software, hardware, and services.

Concurrently, augmented reality and virtual reality for surgical simulation are reducing the learning curve for complex procedures, permitting more rapid clinician onboarding and standardized competency assessments. These immersive technologies are not merely training adjuncts; they are becoming integral to preoperative planning, rehearsal, and intraoperative navigation. The result is a stronger synergy between preoperative analytics and intraoperative execution, improving case efficiency and reducing variability.

Regulatory frameworks and payer attitudes are also shifting to reflect evidence of comparative effectiveness and patient safety. Regulators are increasingly focused on algorithm transparency, real-world performance monitoring, and post-market surveillance, while payers and hospitals evaluate reimbursement pathways that reward outcomes and resource optimization. Taken together, these forces are accelerating ecosystem collaboration among device manufacturers, software developers, health systems, and academic centers, steering the industry toward interoperable, evidence-driven solutions that promise measurable impact on surgical quality and access.

Assessing how the 2025 United States tariff measures are driving supply chain reconfiguration, component sourcing shifts, and resilience strategies across surgical robotics

The introduction of tariffs in the United States in 2025 is exerting measurable pressure on global supply chains for high-precision components and subsystem assemblies used in surgical robotic platforms. Manufacturers that rely on cross-border sourcing of control electronics, imaging modules, and specialized actuators face elevated procurement costs and increased lead-time volatility, prompting strategic shifts in supplier diversification and near-shoring. These adjustments often require requalification of component suppliers and updates to regulatory submissions, introducing additional time and compliance investments.

Hospitals and clinics are feeling downstream effects as procurement cycles lengthen and total cost of ownership calculations become more complex. Capital-intensive acquisitions are subject to reassessment when component inflation alters service contract pricing and replacement part economics. In response, vendors are accelerating vertical integration where feasible, securing long-term supply agreements, and redesigning systems to reduce reliance on tariff-affected inputs. Concurrently, some companies are exploring modular product architectures that permit localized sourcing of non-critical elements while maintaining centralized manufacturing of proprietary subsystems.

Policy responses are also shaping investment and rollout strategies. Organizations with global footprints are reallocating production capacity to jurisdictions with favorable trade terms and stabilizing inventory through strategic stockpiles of critical components. For stakeholders planning multi-year procurement programs, the tariff environment raises the importance of contractual flexibility, indexed pricing clauses, and collaboration with suppliers to mitigate disruption. Overall, the 2025 tariff environment is accelerating resilience planning and driving a reassessment of supply chain and product design priorities across the surgical robotics ecosystem.

Deep segmentation insights revealing how component architecture, autonomy levels, system typologies, clinical applications, and end-user needs shape strategy and differentiation

A granular understanding of market segments reveals distinct technology and commercial dynamics that influence product development and go-to-market strategies. When considering components, hardware categories such as control systems, imaging systems, robotic arms, and sensors and actuators form the backbone of platform performance, while services including installation and training as well as maintenance and support determine lifecycle cost and clinical uptime; software layers comprising AI and machine learning algorithms, augmented and virtual reality for surgical simulation, and data analytics and decision support systems are increasingly the differentiators that deliver clinical value and recurring revenue. Evaluating robotic system types highlights divergence between AI-enabled autonomous robotic systems that prioritize algorithmic decision-making, tethered robotic systems that rely on fixed power or data links and established operating room integration, and untethered robotic systems that offer portability and novel deployment models for constrained environments.

Autonomy level further stratifies offerings into fully autonomous surgical robots designed for closed-loop execution of well-defined procedures, semi-autonomous systems that share control dynamically with the surgeon, and supervised AI-assisted robotics that augment human decision-making without relinquishing procedural control. Application areas create clinical contours for technology deployment, spanning cardiothoracic interventions where precision and vascular control are critical, general surgery with high procedure volume and varied anatomies, gynecological procedures that require minimally invasive dexterity, neurosurgery demanding submillimeter accuracy, orthopedic applications focused on structural alignment, and urology where constrained workspaces are common. End-user considerations are equally consequential: ambulatory surgical centers prioritize throughput and cost-efficiency, hospitals require comprehensive interoperability and service contracts, and specialty clinics demand targeted clinical workflows and reimbursement alignment. Synthesizing these segmentation lenses enables tailored product roadmaps and differentiated commercial strategies that address the unique clinical, operational, and regulatory needs of each segment.

How regional clinical priorities, regulatory landscapes, and manufacturing ecosystems across the Americas, Europe Middle East & Africa, and Asia-Pacific determine strategic market approaches

Regional dynamics shape product prioritization, regulatory engagement, and commercialization strategies in nuanced ways. In the Americas, health systems emphasize large-network procurement, integration with electronic health records, and outcome-driven purchasing, while innovation clusters foster close collaboration between medtech firms and surgical centers to iterate device design and real-world evidence generation. This environment supports rapid pilot deployments but also demands robust evidence on safety and efficiency to secure broader adoption across diverse hospital types.

In Europe, the Middle East & Africa, regulatory harmonization and variable reimbursement landscapes require manufacturers to adopt granular country-level strategies that align clinical value propositions with national procurement frameworks. Europe's established centers of surgical excellence often serve as early adopters for high-complexity systems, whereas markets in the Middle East and Africa may prioritize solutions that improve access and scalability. Manufacturers must therefore balance investment in regulatory approvals and localized training programs with adaptable commercial models.

Across Asia-Pacific, high-growth urban centers are investing in cutting-edge surgical technologies and parallel clinical research collaborations, while other markets prioritize cost-effective and scalable solutions. The region's manufacturing capabilities and component ecosystems also offer opportunities for localized production and shorter supply chains. Understanding these regional distinctions enables companies to tailor product configurations, service offerings, and partnership approaches to match payer expectations, clinical workflows, and infrastructure realities across markets.

Competitive dynamics shaped by incumbents expanding into software ecosystems, startups innovating autonomy, and partnerships driving integrated clinical solutions and differentiation

Competitive dynamics in the surgical robotics arena are defined by a mixture of established medical device firms expanding into software-driven services and agile startups focused on autonomy, niche applications, or novel human-machine interfaces. Leading incumbents retain advantages through expansive installed bases, established hospital relationships, and access to clinical trial networks that support adoption. However, challengers are accelerating by leveraging breakthroughs in machine learning, modular hardware design, and cloud-native software that can be updated iteratively to improve performance and add features post-deployment.

Partnerships between device manufacturers and software specialists are becoming essential to deliver integrated solutions that combine precise actuation with contextual clinical intelligence. In parallel, collaborations with academic centers and surgical societies are critical for building evidence frameworks and clinician trust. Intellectual property around control algorithms, haptic feedback, and safety interlocks remains a strategic asset, while regulatory clearances for algorithmic components are an increasing source of competitive differentiation. Mergers and acquisitions are selectively used to acquire talent, fill product gaps, or accelerate market entry into specialized clinical segments.

For procurement teams, the ability to evaluate vendors on clinical outcomes, total cost of ownership, cybersecurity, and training infrastructure is shifting negotiation dynamics. Companies that demonstrate strong post-market surveillance, upgrade pathways, and transparent performance metrics are more likely to secure long-term contracts and service agreements that underpin sustainable revenue streams.

Actionable strategic priorities for market leaders to balance modular design, regulatory planning, training ecosystems, software monetization, and supply chain resilience

Industry leaders should prioritize a set of strategic actions to capture clinical value while managing risk in a rapidly evolving ecosystem. First, invest in modular product architectures that decouple proprietary subsystems from commodity elements to reduce exposure to tariff-induced cost swings and enable incremental upgrades without full platform replacement. This design approach also supports regional manufacturing flexibility and accelerates time-to-service for international customers. Second, embed regulatory and real-world evidence planning into product development lifecycles to streamline approvals and to build robust outcomes dossiers that payers and health systems require for adoption. Early engagement with regulators and payers will reduce post-market friction and improve reimbursement discussions.

Third, develop comprehensive training and credentialing pathways using immersive simulation and competency-based assessments to shorten learning curves and increase clinical confidence. These programs should be integrated into commercial offerings and coupled with measurable performance metrics. Fourth, create software monetization strategies that balance device sales with recurring revenue from algorithm updates, analytics subscriptions, and outcome-based services. Fifth, strengthen supply chain resilience through supplier diversification, strategic inventories for critical components, and selective vertical integration where feasible. Finally, pursue targeted partnerships with clinical networks and technology firms to co-develop application-specific solutions that demonstrate clear value propositions and facilitate broader acceptance among surgeons and health system leaders.

A robust mixed-methods research methodology combining expert interviews, secondary evidence synthesis, benchmarking, and scenario analysis to validate strategic insights and trends

The research approach underlying these insights combined a structured review of primary qualitative inputs and rigorous secondary-source validation to ensure analytical integrity. Primary engagement included in-depth interviews with surgeons, procurement officers, and device engineers to capture first-hand perspectives on clinical utility, adoption barriers, and procurement considerations. These conversations were complemented by consultations with regulatory specialists and health economics experts to frame compliance and reimbursement implications within operational contexts.

Secondary research synthesized peer-reviewed literature, clinical trial registries, patent filings, and public regulatory databases to corroborate technical claims and trace innovation trajectories. Technology benchmarking assessed control architectures, imaging modalities, and autonomy frameworks to identify common design patterns and points of differentiation. Data triangulation methods reconciled inputs across sources and surfaced consensus findings versus areas of divergence that warrant further investigation. Scenario analysis was applied to examine the implications of policy shocks, supply chain disruptions, and accelerated software deployment on adoption pathways. Together, these methods support a balanced, evidence-informed narrative tailored to decision-makers evaluating strategy, procurement, or investment in surgical robotics.

Concluding synthesis on translating robotics and AI innovation into reproducible clinical value through pragmatic implementation, training, and resilient commercialization

The convergence of advanced robotics, artificial intelligence, and immersive simulation is ushering in a new chapter for surgical care, characterized by enhanced precision, reproducibility, and the potential to expand access to high-quality interventions. Stakeholders must navigate an increasingly complex matrix of clinical evidence requirements, regulatory expectations, and economic pressures while seizing opportunities presented by software-driven differentiation and service-oriented commercial models. Success will depend on the ability to align product design with clinician workflows, demonstrate measurable clinical and operational benefits, and construct resilient supply and support systems.

Looking ahead, the most effective organizations will be those that balance technological ambition with pragmatic implementation strategies: building modular platforms, investing in clinician-centric training, and establishing transparent performance monitoring. Strategic partnerships and flexible commercialization models will accelerate adoption and enable solutions to address diverse clinical settings. Ultimately, the pace and pattern of adoption will be determined by the industry's capacity to translate algorithmic promise into reproducible clinical value and reliable, cost-effective care delivery across health systems.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. AI-based Surgical Robots Market, by Component

  • 8.1. Hardware
    • 8.1.1. Control Systems
    • 8.1.2. Imaging Systems
    • 8.1.3. Robotic Arms
    • 8.1.4. Sensors & Actuators
  • 8.2. Services
    • 8.2.1. Installation & Training
    • 8.2.2. Maintenance & Support
  • 8.3. Software
    • 8.3.1. AI & Machine Learning Algorithms
    • 8.3.2. Augmented Reality (AR) & Virtual Reality (VR) for surgical simulation
    • 8.3.3. Data Analytics & Decision Support Systems

9. AI-based Surgical Robots Market, by Robotic System Type

  • 9.1. AI-Enabled Autonomous Robotic Systems
  • 9.2. Tethered Robotic Systems
  • 9.3. Untethered Robotic Systems

10. AI-based Surgical Robots Market, by Level of Autonomy

  • 10.1. Fully Autonomous Surgical Robots
  • 10.2. Semi-Autonomous Surgical Robots
  • 10.3. Supervised AI-Assisted Robotics

11. AI-based Surgical Robots Market, by Application Areas

  • 11.1. Cardiothoracic Surgery
  • 11.2. General Surgery
  • 11.3. Gynecological Surgery
  • 11.4. Neurosurgery
  • 11.5. Orthopedic Surgery
  • 11.6. Urology Surgery

12. AI-based Surgical Robots Market, by End-User

  • 12.1. Ambulatory Surgical Centers
  • 12.2. Hospitals
  • 12.3. Specialty Clinics

13. AI-based Surgical Robots Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. AI-based Surgical Robots Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. AI-based Surgical Robots Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. United States AI-based Surgical Robots Market

17. China AI-based Surgical Robots Market

18. Competitive Landscape

  • 18.1. Market Concentration Analysis, 2025
    • 18.1.1. Concentration Ratio (CR)
    • 18.1.2. Herfindahl Hirschman Index (HHI)
  • 18.2. Recent Developments & Impact Analysis, 2025
  • 18.3. Product Portfolio Analysis, 2025
  • 18.4. Benchmarking Analysis, 2025
  • 18.5. Accuray Incorporated
  • 18.6. Activ Surgical, Inc.
  • 18.7. Asensus Surgical US, Inc.
  • 18.8. CMR Surgical Limited
  • 18.9. Globus Medical, Inc.
  • 18.10. Intuitive Surgical, Inc.
  • 18.11. Johnson & Johnson Services, Inc.
  • 18.12. KUKA AG
  • 18.13. Medtronic PLC
  • 18.14. Monteris Medical Corporation
  • 18.15. Moon Surgical
  • 18.16. Neocis, Inc.
  • 18.17. Noah Medical Corporation
  • 18.18. Olympus Corporation
  • 18.19. Robocath SAS
  • 18.20. Shimadzu Corporation
  • 18.21. Siemens AG
  • 18.22. Smith & Nephew PLC
  • 18.23. Stereotaxis, Inc.
  • 18.24. Stryker Corporation
  • 18.25. Synaptive Medical Inc.
  • 18.26. THINK Surgical, Inc.
  • 18.27. Titan Medical Inc.
  • 18.28. Virtual Incision Corporation
  • 18.29. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL AI-BASED SURGICAL ROBOTS MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 13. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CONTROL SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY IMAGING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC ARMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SENSORS & ACTUATORS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY INSTALLATION & TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY MAINTENANCE & SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI & MACHINE LEARNING ALGORITHMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AUGMENTED REALITY (AR) & VIRTUAL REALITY (VR) FOR SURGICAL SIMULATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY DATA ANALYTICS & DECISION SUPPORT SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AI-ENABLED AUTONOMOUS ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY TETHERED ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UNTETHERED ROBOTIC SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY FULLY AUTONOMOUS SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SEMI-AUTONOMOUS SURGICAL ROBOTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUPERVISED AI-ASSISTED ROBOTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY CARDIOTHORACIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GENERAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GYNECOLOGICAL SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY NEUROSURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY UROLOGY SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 93. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 101. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 167. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 174. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 175. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 176. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 178. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 181. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 182. GCC AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 192. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 194. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 201. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 203. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 205. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 208. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 209. G7 AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 210. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 212. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 214. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 217. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 218. NATO AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 220. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 221. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 222. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)
  • TABLE 229. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 230. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 231. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY HARDWARE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY ROBOTIC SYSTEM TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY LEVEL OF AUTONOMY, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY APPLICATION AREAS, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA AI-BASED SURGICAL ROBOTS MARKET SIZE, BY END-USER, 2018-2032 (USD MILLION)